Similar Items: Early Myelosuppression Secondary to Linezolid Use in the Context of Hematologic Malignancy
- Survival of Hematologic Malignancy In Patients With Early‐Stage Chronic Kidney Disease (SHIP‐CKD)
- Hippo-YAP/TAZ Signaling in Hematological Malignancies: Molecular Mechanisms, Pathway Crosstalk and Therapeutic Potential
- The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib
- Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study
- Research on Targeted Therapy for Malignant Tumors of the Biliary Tract
- Hematologic Glyco-Signatures: Emerging Blood-Based Sugar Codes Linked to Hyper-Aggressive Breast Cancer